Vanguard Global Advisers’s AbbVie ABBV Stock Holding History

Vanguard Global Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$964M	Sell	3,829,319 -76,339	-2%	-$16.4M	0.45%	34
2026 Q1	$849M	Buy	+3,905,658	New	+$866M	0.46%	30

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Global Advisers's ABBV Position: Q2 2026 in Review

Vanguard Global Advisers reduced its AbbVie (ABBV) stake by 2% in Q2 2026, selling an estimated $16.4M and leaving 3,829,319 shares worth $964M. The position accounts for 0.45% of the portfolio, ranked #34.

Vanguard Global Advisers first reported a position in ABBV in Q1 2026 and has held it in 2 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Vanguard Global Advisers held 3,829,319 shares of AbbVie worth $964M as of Q2 2026.
Vanguard Global Advisers sold 76,339 AbbVie shares in Q2 2026, an estimated $16.4M.
AbbVie made up 0.45% of Vanguard Global Advisers's portfolio in Q2 2026, its #34 holding.
Vanguard Global Advisers first reported a position in AbbVie in Q1 2026 and has held it in 2 quarters since.
4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.